Table 4.
Kidney complications and outcomes of rapid progression and slow progression during the follow-up period
| Variables | RP (N = 426) | SP (N = 342) | P value |
|---|---|---|---|
| Renal event (%) | |||
| Cyst infection | 33 (7.7) | 7 (2.0) | <0.01 |
| Cyst hemorrhage | 26 (6.1) | 5 (1.4) | <0.01 |
| Proteinuria | 102(23.9) | 53(15.5) | <0.01 |
| Kidney stones | 49(11.5) | 3710.8) | 0.93 |
| Gross hematuria | 44(10.3) | 23(6.7) | 0.12 |
| Chronic pain | 19(4.5) | 14(4.1) | 0.94 |
| Upper UTI | 13(3.1) | 7(2.0) | 0.45 |
| Outcome events (%) | |||
| Progressed to ESKD | 59 (13.9) | 7 (2.1) | <0.01 |
ESKD, end-stage kidney disease; RP, rapid progressor; SP, slow progressor.